@indianalytics@BioSpecExeter Thanks very much! No, thankfully water isn't an issue with Raman - it only has contributions in the high wavenumber region which we aren't using in this specific work.
Excited to share my first #RSCPoster detailing my work with tissue phantoms to help inform the development of a novel breast cancer screening modality using Raman spectroscopy @BioSpecExeter#RSCPoster2020#RSCAnalytical
@nickgregoirenc@BioSpecExeter Assessing the limitations is a work in progress - something we are working on in particular is fact that fat produces peaks in a very similar area to the one we are interested in. I realise that's not a lot of detail π I will happily explain more if needed.
@nickgregoirenc@BioSpecExeter Yes, exactly. The hope is that the Raman will provide extra information to add to that from the x-ray which may provide enough clarity to remove the need for biopsy in some patients.
@nickgregoirenc@BioSpecExeter Thank you! In theory, it should be quite practical - as TRS involves a set up with the laser incident on one side of the sample and the detector on the other, we would be able to apply this in a similar way to standard mammography.
@ZJAyres@BioSpecExeter However, there is also a relation between the carbonate content of Type II and disease status which we intend to investigate further - carbonate content decreases from benign to malignant disease.
@ZJAyres@BioSpecExeter Hi Zoe, thank you very much, glad you like it! You're right, there is some crossover. Type I calcifications are less common but are generally found in benign disease, but Type II can also be present in benign lesions.